PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.96%
Revenue growth similar to 3141.T's 5.03%. Walter Schloss would see if both companies share industry tailwinds.
8.17%
Gross profit growth above 1.5x 3141.T's 0.14%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
24.49%
EBIT growth above 1.5x 3141.T's 10.63%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
28.69%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
-17.71%
Negative net income growth while 3141.T stands at 4.39%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.71%
Negative EPS growth while 3141.T is at 4.42%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.71%
Negative diluted EPS growth while 3141.T is at 4.27%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 3141.T's 0.04%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 3141.T's 0.11%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.57%
10Y revenue/share CAGR under 50% of 3141.T's 85.36%. Michael Burry would suspect a lasting competitive disadvantage.
-15.64%
Negative 5Y CAGR while 3141.T stands at 61.99%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
32.43%
3Y revenue/share CAGR at 50-75% of 3141.T's 46.82%. Martin Whitman would question if the firm lags behind competitor innovations.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.27%
Below 50% of 3141.T's 296.36%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-21.87%
Negative 5Y net income/share CAGR while 3141.T is 191.04%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
70.89%
3Y net income/share CAGR 50-75% of 3141.T's 111.62%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
24.39%
Below 50% of 3141.T's 115.65%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
70.99%
3Y equity/share CAGR above 1.5x 3141.T's 46.06%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-100.00%
Cut dividends over 10 years while 3141.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.55%
AR growth is negative/stable vs. 3141.T's 14.99%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.14%
Inventory shrinking or stable vs. 3141.T's 8.00%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.08%
Asset growth well under 50% of 3141.T's 4.49%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.03%
1.25-1.5x 3141.T's 3.05%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-30.60%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
94.28%
SG&A growth well above 3141.T's 43.50%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.